News that the U.S. Department of Justice is going to court to block Anthem's efforts to acquire Cigna Corp. and Aetna's effort to acquire Humana raises an important question: How much cash could the acquisition targets get if the deals die?
Indianapolis-based Anthem has been trying to acquire Bloomfield, Connecticut-based Cigna for about $48 billion in cash and stock. Hartford-based Aetna agreed to pay about $37 billion in cash and stock for Louisville, Kentucky-based Humana.
Like most publicly traded companies involved in major deals, negotiators included provisions for what might happen if the deals collapsed in both the Anthem-Cigna merger agreement and the Aetna-Humana agreement.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Allison Bell
Allison Bell, a senior reporter at ThinkAdvisor and BenefitsPRO, previously was an associate editor at National Underwriter Life & Health. She has a bachelor's degree in economics from Washington University in St. Louis and a master's degree in journalism from the Medill School of Journalism at Northwestern University. She can be reached through X at @Think_Allison.
